CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. CK Life Sciences Int'l., (Holdings) Inc. was founded in 1999 and is headquartered in Tai Po, Hong Kong.
CK Life Sciences Dividend Announcement
• CK Life Sciences announced a annually dividend of HK$0.01 per ordinary share which will be made payable on 2023-06-05. Ex dividend date: 2023-05-23
• CK Life Sciences annual dividend for 2023 was HK$0.01
• CK Life Sciences's trailing twelve-month (TTM) dividend yield is -%
• CK Life Sciences's dividend growth over the last five years (2018-2023) was -4.36% year
• CK Life Sciences's dividend growth over the last ten years (2013-2023) was 2.92% year
CK Life Sciences Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-05-23 | HK$0.01 | annually | 2023-06-05 |
2022-05-20 | HK$0.01 | annually | 2022-06-01 |
2021-05-18 | HK$0.01 | annually | 2021-05-31 |
2020-05-19 | HK$0.01 | annually | 2020-05-29 |
2019-05-21 | HK$0.01 | annually | 2019-05-31 |
2018-05-15 | HK$0.01 | annually | 2018-05-28 |
2017-05-16 | HK$0.01 | annually | 2017-05-26 |
2016-05-18 | HK$0.01 | annually | |
2015-05-20 | HK$0.01 | annually | |
2014-05-20 | HK$0.01 | annually | |
2013-05-23 | HK$0.01 | annually | |
2012-05-29 | HK$0.01 | annually |
CK Life Sciences Dividend per year
CK Life Sciences Dividend growth
CK Life Sciences Dividend Yield
CK Life Sciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing CK Life Sciences stock? Use our calculator to estimate your expected dividend yield:
CK Life Sciences Financial Ratios
CK Life Sciences Dividend FAQ
Other factors to consider when evaluating CK Life Sciences as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy CK Life Sciences stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: CK Life Sciences's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, CK Life Sciences publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, CK Life Sciences distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from CK Life Sciences are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: CK Life Sciences sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, CK Life Sciences distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: CK Life Sciences declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of CK Life Sciences's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review CK Life Sciences's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.